Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2026-03-12 @ 5:31 AM
Study NCT ID:
NCT05017233
Status:
TERMINATED
Last Update Posted:
2024-05-17
First Post:
2021-08-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Spectral CT Clinical Trial Protocol
Sponsor:
Philips (China) Investment CO., LTD
Organization:
Study Overview
Official Title:
Spectral CT Clinical Trial Protocol
Status:
TERMINATED
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Investigational product had been released in NMPA, Sponsor decided to terminate the study aligned with investigator
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study was to evaluate the expected effectiveness, ease of operation, stability, and safety of Spectral CT
Detailed Description:
Under the premise of protecting subjects and ensuring the scientific nature of this study, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal conditions by collecting clinical cases.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?: